[go: up one dir, main page]

GB201522414D0 - Monoamine oxidase B binders - Google Patents

Monoamine oxidase B binders

Info

Publication number
GB201522414D0
GB201522414D0 GBGB1522414.0A GB201522414A GB201522414D0 GB 201522414 D0 GB201522414 D0 GB 201522414D0 GB 201522414 A GB201522414 A GB 201522414A GB 201522414 D0 GB201522414 D0 GB 201522414D0
Authority
GB
United Kingdom
Prior art keywords
binders
monoamine oxidase
monoamine
oxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1522414.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLINO Ltd
Original Assignee
CLINO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLINO Ltd filed Critical CLINO Ltd
Priority to GBGB1522414.0A priority Critical patent/GB201522414D0/en
Publication of GB201522414D0 publication Critical patent/GB201522414D0/en
Priority to PCT/EP2016/081704 priority patent/WO2017103257A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1522414.0A 2015-12-18 2015-12-18 Monoamine oxidase B binders Ceased GB201522414D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1522414.0A GB201522414D0 (en) 2015-12-18 2015-12-18 Monoamine oxidase B binders
PCT/EP2016/081704 WO2017103257A1 (en) 2015-12-18 2016-12-19 Monoamine oxidase b binders for use in the treatment and the diagnostic of alzheimer disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1522414.0A GB201522414D0 (en) 2015-12-18 2015-12-18 Monoamine oxidase B binders

Publications (1)

Publication Number Publication Date
GB201522414D0 true GB201522414D0 (en) 2016-02-03

Family

ID=55311246

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1522414.0A Ceased GB201522414D0 (en) 2015-12-18 2015-12-18 Monoamine oxidase B binders

Country Status (2)

Country Link
GB (1) GB201522414D0 (en)
WO (1) WO2017103257A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7284490B2 (en) 2018-08-07 2023-05-31 国立大学法人東北大学 Monoamine oxidase B imaging probe
KR20260006897A (en) * 2024-07-05 2026-01-13 한국과학기술연구원 Novel MAO-B inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012521988A (en) * 2009-03-23 2012-09-20 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Imaging agents for detecting neurological disorders
JP5928901B2 (en) * 2010-10-29 2016-06-01 クリノ株式会社 Tau imaging probe
SG10201803294PA (en) * 2013-10-22 2018-06-28 Clino Ltd Tau imaging probe
KR101696061B1 (en) * 2015-03-05 2017-01-13 재단법인 아산사회복지재단 Methods and apparatus for acquiring image based biomarkers suitable for diagnosis of neurodegenerative diseases and methods for diagnosing neurodegenerative diseases

Also Published As

Publication number Publication date
WO2017103257A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
ZA201905396B (en) Trans-replicating rna
IL256419B (en) Binding machine
PL3146010T3 (en) Binders
IL255194B (en) Solid forms
GB2540441B (en) Amplifiers
SI3237350T1 (en) Improved binder
GB201511969D0 (en) Biosensor
IL253635A0 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
GB201610063D0 (en) Binders
IL257500A (en) Modified cullin1 gene
HUE046930T2 (en) Odour-masked amine composition
GB201412335D0 (en) Binder
PL3256331T3 (en) Document
GB2537722B (en) Booklet
AU201612214S (en) Plates
SG11201604873TA (en) Improved ngs workflow
GB201413311D0 (en) Book
GB201522414D0 (en) Monoamine oxidase B binders
SI3393992T1 (en) Binder comprising oxocarbon
SG11201702252QA (en) Binding tool
ZA201801356B (en) Firelighter
GB201518350D0 (en) Binding rings
GB201521974D0 (en) Equestrian polecaddy
GB201521485D0 (en) .
GB201521036D0 (en) Calligrapy Paper

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)